Dan Gorenstein

For decades, nonprofits, health insurers and hospitals have been trying to solve the problem of the people who need the emergency room again and again. Here are some of the lessons they've learned.

Sometimes health care means being able to go out and watch a wrestling match, according to Dr. Clarissa Kripke. She's pioneering a new kind of care for people with disabilities.

The 3-digit suicide prevention lifeline went live a year ago. More work is needed on the 988 system, but the first year has gone more smoothly than many expected.

Powerful new artificial intelligence tools can perpetuate long-standing racial inequities if they are not designed very carefully. Researchers and regulators are taking note, but perils are vast.

The end-of-life benefit costs billions a year. A new approach aims to eliminate waste and weed out bad actors, while making the care more inviting to those who most need it.

People leaving jail or prison are at extremely high risk of hospitalization and death, and policymakers from deep blue California to solidly red Utah think bringing Medicaid behind bars could help.

She's seen what happens when people don't trust or understand their doctor. Dr. Lisa Fitzpatrick founded 'Grapevine Health' to get solid information out, especially to Black and Latinx patients.

Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.

U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.

The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already lobbying to dull their impact.